Senseonics FY2026 Earnings Forecast Raised by HC Wainwright

Senseonics Holdings, Inc. (NASDAQ:SENS – Free Report) – Analysts at HC Wainwright boosted their FY2026 earnings per share estimates for shares of Senseonics in a research report issued to clients and investors on Tuesday, November 10th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings per share of ($2.35) for the year, up from their previous estimate of ($2.41). HC Wainwright has a “Buy” rating and a $14.00 price target on the stock. The consensus estimate for Senseonics’ current full-year earnings is ($2.20) per share. HC Wainwright also issued estimates for Senseonics’ Q4 2026 earnings at ($0.54) EPS, Q1 2027 earnings at ($0.64) EPS, Q2 2027 earnings at ($0.59) EPS, Q3 2027 earnings at ($0.47) EPS, Q4 2027 earnings at ($0.41) EPS, FY2027 earnings at ($2.13) EPS, FY2028 earnings at ($1.56) EPS, FY2029 earnings at ($1.04) EPS and FY2030 earnings at ($0.48) EPS.

Other analysts have also issued reports about the company. TD Cowen boosted their price target on Senseonics from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday. Weiss Ratings raised shares of Senseonics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. Raymond James Financial upgraded shares of Senseonics from an “underperform” rating to a “market perform” rating in a report on Tuesday. Stifel Nicolaus reaffirmed a “hold” rating and issued a $10.00 target price (up from $9.00) on shares of Senseonics in a research report on Tuesday. Finally, Wall Street Zen upgraded shares of Senseonics from a “sell” rating to a “hold” rating in a research note on Saturday. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Senseonics has a consensus rating of “Hold” and a consensus target price of $14.40.

Read Our Latest Report on Senseonics

Senseonics Trading Up 5.4%

Shares of SENS opened at $10.58 on Thursday. Senseonics has a twelve month low of $4.79 and a twelve month high of $13.98. The firm’s 50 day moving average price is $9.17 and its two-hundred day moving average price is $7.33. The company has a quick ratio of 6.40, a current ratio of 5.92 and a debt-to-equity ratio of 0.70.

Senseonics (NASDAQ:SENS – Get Free Report) last posted its earnings results on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative return on equity of 186.11% and a negative net margin of 204.01%. The business had revenue of $19.56 million for the quarter.

Insider Buying and Selling

In related news, Director Douglas Roeder purchased 13,953 shares of Senseonics stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average cost of $8.98 per share, with a total value of $125,297.94. Following the completion of the transaction, the director owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.70% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Empowered Funds LLC bought a new position in shares of Senseonics in the third quarter valued at $621,000. Ieq Capital LLC acquired a new position in Senseonics during the third quarter worth $215,000. StoneX Group Inc. acquired a new position in Senseonics during the third quarter worth $128,000. Traynor Capital Management Inc. acquired a new position in Senseonics during the third quarter worth $152,000. Finally, State of Wyoming raised its position in Senseonics by 27.2% during the third quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after acquiring an additional 3,199 shares in the last quarter. Institutional investors and hedge funds own 12.36% of the company’s stock.

Top Senseonics Stories

Investors following SENS have been watching these stories:

  • Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $14 price target. It also raised some longer-term EPS estimates, including for FY2026 and FY2028–FY2030, signaling some improvement in its longer-range outlook. HC Wainwright rating HC Wainwright earnings estimate revisions
  • Neutral Sentiment: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. These stances are more cautious than a Buy recommendation but do not signal an outright bearish view. Stifel rating Raymond James rating
  • Negative Sentiment: HC Wainwright lowered several 2026–2027 quarterly EPS forecasts and its FY2027 estimate, reflecting expectations of larger losses in those periods. This tempers the positive longer-term revisions. HC Wainwright earnings estimate revisions

About Senseonics

(Get Free Report)

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.

Read More

Earnings History and Estimates for Senseonics (NASDAQ:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.